Jurata Thin Film is a biotechnology company developing thin-film formulations that immobilize vaccines and biologics into a solid matrix to preserve therapeutic activity at room temperature for up to three years. The technology, originating in the lab of Maria Croyle at the University of Texas at Austin, is intended to simplify manufacturing, distribution, storage, and delivery of vaccines and biologics. Jurata’s films can be administered sublingually or buccally, or rehydrated for intramuscular injection, and the company is pursuing toxicity and regulatory testing for those routes. The company plans to use new funding to design and build a pilot-scale manufacturing line capable of fabricating over 1,000 doses per hour. Raised funds will also support additional R&D hires to support client evaluation projects and broaden the technology’s applicability. Jurata was founded in 2019 and is based in Houston, TX.

Total raised

$5M

Funding rounds

1

Latest round

Seed

Latest activity

Nov 2022